AAV Mediated Expression of Mouse IL-12 Shows Potent Anti-Tumor Activity and Immune Response Alone and in Combination with Anti-PD1 in Syngeneic Murine Tumor Models

被引：0
|
作者：
Sutton, David [1 ]
Prentiss, Pilar [1 ]
Furmanski, Brian [1 ]
机构：
[1] Kriya Therapeut, Translat Dev, Redwood City, CA USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
337
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [31] A highly potent HPK1 inhibitor augments immune cell activation and anti-tumor immunity in a syngeneic tumor mouse model
    Liu, Hao
    Wu, Lei
    Feng, Song
    Huang, Wei
    Li, Huijuan
    Lin, Jing
    Liu, Yangyang
    Mei, Liufeng
    Ren, Baoqi
    Xie, Julie
    Yao, Lili
    Zhong, Wenge
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [32] Tumor treating fields (TTFields) elicit an anti-tumor immune response and in combination enhance anti-PD-1 treatment efficacy
    Kaynan, Noa
    Voloshin, Tali
    Davidi, Shiri
    Porat, Yaara
    Shteingauz, Anna
    Munster, Mijal
    Schneiderman, Rosa
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models
    Kandaswamy, Veena
    Forest, Amelie
    Deroose, Marianne
    Schaer, David A.
    Chen, Ting
    Liu, Shengwu
    Surguladze, David
    Yao, Yung-mae
    Doman, Thompson
    Hall, Gerald
    Wong, Kwok-Kin
    Kalos, Michael
    Novosiadly, Ruslan D.
    CANCER RESEARCH, 2018, 78 (13)
  • [34] Molecular characterization of mouse syngeneic tumor models in response to treatment with anti-PD-1 immunotherapy
    Hirsch, Heather A.
    Pinheiro, Elaine M.
    Cai, Mingmei
    Ma, Yanhong
    Sathe, Manjiri
    Ayers, Mark
    McClanahan, Terrill K.
    CANCER RESEARCH, 2015, 75
  • [35] The IV STING agonist, TAK-676, enhances immune-mediated anti-tumor activity of radiation in syngeneic mouse models
    Appleman, Vicky A.
    Berger, Allison J.
    Roberts, Emily R.
    Maldonado-Lopez, Angel E.
    Ganno, Michelle L.
    Christensen, Camilla I.
    Hatten, Tiquella
    Sato, Yosuke
    Shaw, Michael H.
    Malek, Karim S.
    Lineberry, Neil B.
    Abu-Yousif, Adnan O.
    Gregory, Richard C.
    CANCER RESEARCH, 2022, 82 (12)
  • [36] huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models
    Kin-Ming Lo
    Yan Lan
    Scott Lauder
    Jinyang Zhang
    Beatrice Brunkhorst
    Guozhong Qin
    Rakesh Verma
    Nigel Courtenay-Luck
    Stephen D. Gillies
    Cancer Immunology, Immunotherapy, 2007, 56 : 447 - 457
  • [37] Anti-tumor activity of intratumoral xenogeneic urothelial cell monotherapy or in combination with chemotherapy in syngeneic murine models of bladder cancer
    Huang, Chi-Ping
    Lu, Hsin-Ling
    Shyr, Chih-Rong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (06): : 2285 - 2306
  • [38] huBC1-IL12, an immunocytokine which targets EDB-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models
    Lo, Kin-Ming
    Lan, Yan
    Lauder, Scott
    Zhang, Jinyang
    Brunkhorst, Beatrice
    Qin, Guozhong
    Verma, Rakesh
    Courtenay-Luck, Nigel
    Gillies, Stephen D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (04) : 447 - 457
  • [39] Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
    Naoto Kunimura
    Koichi Kitagawa
    Ryota Sako
    Keita Narikiyo
    Shoko Tominaga
    Diosdado S. Bautista
    Wei Xu
    Masato Fujisawa
    Toshiro Shirakawa
    Scientific Reports, 10
  • [40] Combination of rAd-p53 in situ gene therapy and anti-PD-1 antibody immunotherapy induced anti-tumor activity in mouse syngeneic urogenital cancer models
    Kunimura, Naoto
    Kitagawa, Koichi
    Sako, Ryota
    Narikiyo, Keita
    Tominaga, Shoko
    Bautista, Diosdado S.
    Xu, Wei
    Fujisawa, Masato
    Shirakawa, Toshiro
    SCIENTIFIC REPORTS, 2020, 10 (01)
12345